Zimmer Biomet Holdings Net Profit Margin 2006-2019 | ZBH
Current and historical net profit margin for Zimmer Biomet Holdings (ZBH) from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue. Zimmer Biomet Holdings net profit margin for the three months ending December 31, 2019 was .
| Zimmer Biomet Holdings Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2019-12-31 | $7.98B | $1.13B | 14.18% |
| 2019-09-30 | $7.93B | $-0.09B | -1.14% |
| 2019-06-30 | $7.87B | $-0.36B | -4.56% |
| 2019-03-31 | $7.89B | $-0.31B | -3.90% |
| 2018-12-31 | $7.93B | $-0.38B | -4.78% |
| 2018-09-30 | $7.93B | $1.75B | 22.10% |
| 2018-06-30 | $7.91B | $1.69B | 21.37% |
| 2018-03-31 | $7.85B | $1.69B | 21.52% |
| 2017-12-31 | $7.80B | $1.81B | 23.23% |
| 2017-09-30 | $7.73B | $0.65B | 8.43% |
| 2017-06-30 | $7.75B | $0.71B | 9.18% |
| 2017-03-31 | $7.74B | $0.50B | 6.42% |
| 2016-12-31 | $7.67B | $0.31B | 4.00% |
| 2016-09-30 | $7.61B | $0.36B | 4.79% |
| 2016-06-30 | $7.53B | $0.23B | 3.01% |
| 2016-03-31 | $6.77B | $0.08B | 1.24% |
| 2015-12-31 | $6.00B | $0.15B | 2.43% |
| 2015-09-30 | $5.29B | $0.17B | 3.18% |
| 2015-06-30 | $4.63B | $0.32B | 6.89% |
| 2015-03-31 | $4.65B | $0.67B | 14.42% |
| 2014-12-31 | $4.67B | $0.72B | 15.43% |
| 2014-09-30 | $4.69B | $0.83B | 17.63% |
| 2014-06-30 | $4.66B | $0.81B | 17.34% |
| 2014-03-31 | $4.65B | $0.78B | 16.85% |
| 2013-12-31 | $4.62B | $0.78B | 16.87% |
| 2013-09-30 | $4.56B | $0.68B | 14.86% |
| 2013-06-30 | $4.52B | $0.70B | 15.54% |
| 2013-03-31 | $4.47B | $0.77B | 17.11% |
| 2012-12-31 | $4.47B | $0.76B | 16.90% |
| 2012-09-30 | $4.46B | $0.76B | 17.04% |
| 2012-06-30 | $4.47B | $0.77B | 17.33% |
| 2012-03-31 | $4.48B | $0.76B | 17.04% |
| 2011-12-31 | $4.45B | $0.76B | 17.12% |
| 2011-09-30 | $4.42B | $0.64B | 14.48% |
| 2011-06-30 | $4.35B | $0.64B | 14.68% |
| 2011-03-31 | $4.27B | $0.60B | 14.06% |
| 2010-12-31 | $4.22B | $0.60B | 14.14% |
| 2010-09-30 | $4.19B | $0.72B | 17.10% |
| 2010-06-30 | $4.20B | $0.68B | 16.08% |
| 2010-03-31 | $4.17B | $0.72B | 17.28% |
| 2009-12-31 | $4.10B | $0.72B | 17.50% |
| 2009-09-30 | $4.02B | $0.73B | 18.16% |
| 2009-06-30 | $4.00B | $0.80B | 19.90% |
| 2009-03-31 | $4.06B | $0.81B | 20.02% |
| 2008-12-31 | $4.12B | $0.85B | 20.60% |
| 2008-09-30 | $4.17B | $0.95B | 22.69% |
| 2008-06-30 | $4.12B | $0.78B | 18.83% |
| 2008-03-31 | $4.01B | $0.78B | 19.47% |
| 2007-12-31 | $3.90B | $0.77B | 19.86% |
| 2007-09-30 | $3.76B | $0.76B | 20.09% |
| 2007-06-30 | $3.68B | $0.89B | 24.30% |
| 2007-03-31 | $3.59B | $0.86B | 24.04% |
| 2006-12-31 | $3.50B | $0.84B | 23.88% |
| 2006-09-30 | $3.41B | $0.79B | 23.17% |
| 2006-06-30 | $3.35B | $0.78B | 23.14% |
| 2006-03-31 | $3.32B | $0.77B | 23.09% |
| 2005-12-31 | $3.29B | $0.73B | 22.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.991B | $7.982B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $140.105B | 24.52 |
| Medtronic (MDT) | Ireland | $115.616B | 15.54 |
| Stryker (SYK) | United States | $55.501B | 17.93 |
| Boston Scientific (BSX) | United States | $43.519B | 19.60 |
| Baxter (BAX) | United States | $41.301B | 0.00 |
| Coloplast (CLPBY) | Denmark | $32.381B | 49.97 |
| Lonza Group Ag (LZAGY) | Switzerland | $30.517B | 0.00 |
| Terumo (TRUMY) | Japan | $24.814B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $23.088B | 0.00 |
| ResMed (RMD) | United States | $22.122B | 38.44 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.868B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $14.665B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.946B | 51.16 |
| Insulet (PODD) | United States | $10.367B | 634.31 |
| William Demant Holdings (WILYY) | Denmark | $7.898B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.034B | 20.23 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.994B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.057B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.039B | 11.01 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Haemonetics (HAE) | United States | $4.949B | 30.46 |
| Canopy Growth (CGC) | Canada | $4.629B | 0.00 |
| ICU Medical (ICUI) | United States | $4.256B | 27.80 |
| Quidel (QDEL) | United States | $3.979B | 34.93 |
| Neogen (NEOG) | United States | $3.373B | 57.14 |
| Agios Pharmaceuticals (AGIO) | United States | $2.569B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.529B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.354B | 0.00 |
| NuVasive (NUVA) | United States | $2.269B | 17.54 |
| Envista Holdings (NVST) | United States | $2.062B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.337B | 22.53 |
| AtriCure (ATRC) | United States | $1.273B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.210B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.986B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.979B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.961B | 19.01 |
| NanoString Technologies (NSTG) | United States | $0.862B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.798B | 16.58 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.761B | 0.00 |
| Aphria (APHA) | $0.754B | 0.00 | |
| Cerus (CERS) | United States | $0.741B | 0.00 |
| Omeros (OMER) | United States | $0.663B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.639B | 79.31 |
| InMode (INMD) | Israel | $0.619B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.595B | 35.39 |
| PetIQ (PETQ) | United States | $0.582B | 15.83 |
| Quanterix (QTRX) | United States | $0.547B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.462B | 26.00 |
| Surmodics (SRDX) | United States | $0.432B | 49.69 |
| Owens & Minor (OMI) | United States | $0.427B | 11.69 |
| Lantheus Holdings (LNTH) | United States | $0.411B | 9.23 |
| Vapotherm (VAPO) | United States | $0.381B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.363B | 14.60 |
| Zynex (ZYXI) | United States | $0.327B | 35.61 |
| Repro-Med Systems (KRMD) | United States | $0.298B | 188.00 |
| Utah Medical Products (UTMD) | United States | $0.292B | 20.87 |
| Organigram Holdings (OGI) | Canada | $0.280B | 0.00 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.236B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.201B | 123.00 |
| Female Health (VERU) | United States | $0.196B | 0.00 |
| HEXO (HEXO) | $0.192B | 0.00 | |
| Viemed Healthcare (VMD) | United States | $0.164B | 18.52 |
| Exagen (XGN) | United States | $0.162B | 0.00 |
| United Health Products (UEEC) | United States | $0.132B | 0.00 |
| Evolus (EOLS) | United States | $0.130B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.124B | 0.00 |
| Bovie Medical (APYX) | United States | $0.122B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.121B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.110B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 6.78 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.069B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.061B | 12.69 |
| Nephros (NEPH) | United States | $0.058B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| Surface Oncology (SURF) | United States | $0.047B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.037B | 0.00 |
| ImmuCell (ICCC) | United States | $0.030B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.024B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.024B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.023B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.002B | 0.00 |
